Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous morphine infusion vs oral long-acting opioids for cancer pain control
KCT0008879Phase 4Withdrawn
- Sponsor
- Chungnam National University Sejong Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of morphine in cancer, sponsored by Chungnam National University Sejong Hospital. Planned start Jan 2026; status: withdrawn.
02
Drugs
morphine
03
Conditions
cancer
Beyond the preview
Go deeper on KCT0008879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008879.